Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
Abetis is indicated for the treatment of type 2 diabetes mellitus to improve glycemic control as monotherapy or in combination with other antidiabetic agents.
Pharmacology:
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin levels, which inhibit glucagon release, increase insulin secretion, and decrease blood glucose levels.
Dosage & Administration:
The recommended dose is 40 mg once daily, with or without food. Dose adjustments may be required in renal impairment.
Interaction:
May interact with other antidiabetic drugs and medications affecting renal function.
Contraindications:
Contraindicated in patients with hypersensitivity to Sitagliptin.
Side Effects:
Common side effects include headache, nasopharyngitis, and upper respiratory tract infection. Rarely, pancreatitis may occur.
Pregnancy & Lactation:
Use during pregnancy only if clearly needed. Caution advised during breastfeeding.
Precautions & Warnings:
Monitor blood glucose levels regularly. Use with caution in patients with renal impairment.
Therapeutic Class:
Dipeptidyl peptidase-4 (DPP-4) inhibitors
Storage Conditions:
Store in a cool, dry place below 30°C, protected from moisture and light. Keep out of reach of children.
 48 Pcs.jpg)
.jpeg)
4 pcs.webp)
 24 PCS.jpg)
 kg 24 pcs.jpg)
.png)
 50 Pcs.jpg)
.jpg)
.jpg)
32 pcs.jpg)
.jpg)
32 pcs.jpeg)
.jpg)
.jpg)
 04 Pcs.jpg)
.webp)
.jpg)
.webp)
 05 Pcs.jpg)
 60Pcs.webp)
 04 Pcs.png)
 50ML..webp)
 BELT 36PCS.jpg)
.webp)
 05 Pcs.jpg)
 300ml.jpeg)
4 pcs.jpg)
.jpeg)
Change Language